| 1 day |
| -0.86% | |||
| 1 week | +0.06% |
| |||
| 4 week | +6.07% |
| |||
| 3 month | +8.74% |
| |||
| YTD | +10.88% |
| |||
| 1 year | +32.25% |
| |||
| 3 years* | +13.43% |
| |||
| 5 years* |
| -1.27% | |||
| *annualized | |||||
| Best 3 month return | +31.66% | |
| Worst 3 month return | -35.15% |
| Return | Risk | Rating | |
| 3 years | Above Average | Average |
|
| 5 years | Above Average | Average |
|
| 10 years | Average | Average |
|
| Overall | Above Average | Average |
|
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
| Total assets | 4.71B | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.44% | |
| Management fee | - | |
| Fund family | GMO |
| Cash | 2.59% | |
| Stocks | 97.53% | |
| Bonds | 0.00% | |
| Other | -0.12% |
| Initial | $300,000,000 |
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 0.72 | 0.99 | 0.06 | 0.14 | |
| Beta* | 0.98 | 0.98 | 0.98 | 0.98 | |
| Mean annual return | 1.63 | 0.82 | 0.15 | 0.88 | |
| R-squared* | 96.10 | 97.70 | 97.84 | 97.34 | |
| Standard deviation | 16.29 | 19.33 | 23.04 | 18.18 | |
| Sharpe ratio | 1.19 | 0.51 | 0.07 | 0.49 | |
| * Against standard index | |||||
| Security | Net Assets | |
| Total SA (FP) | 3.77% | |
| Sanofi (SAN) | 2.84% | |
| Future Contract On S&P/Tsx 60 Ix Fut Mar13 /Cad/ | 2.50% | |
| AstraZeneca PLC (AZN) | 2.32% | |
| BP PLC (BPAQF) | 2.31% | |
| Banco Santander SA (BCDRF) | 2.00% | |
| GMO US Treasury | 1.90% | |
| Future Contract On Ftse/Mib Idx Fut Mar13 /Eur/ | 1.89% | |
| Rio Tinto PLC (RTPPF) | 1.76% | |
| E. On SE (ENAKF) | 1.60% |